Literature DB >> 3689629

Inhibition of exercise-induced asthma by nifedipine: a dose-response study.

P Rafferty1, J G Varley, J S Edwards, S T Holgate.   

Abstract

1. The effect of three single doses of nifedipine on exercise-induced asthma has been examined in 11 asthmatic subjects. 2. On four separate days patients undertook 6 min of exercise on a treadmill 30 min after taking placebo or nifedipine 10, 20 or 30 mg administered double-blind and in random order. 3. Nifedipine had no significant effect on resting FEV1 measurements. 4. Nifedipine, in doses of 10, 20 and 30 mg, inhibited exercise induced bronchoconstriction, reducing the maximum fall in FEV1 from 30.8 +/- 3.5% after placebo to 21.9 +/- 3.4% (NS), 13 +/- 3.4% (P less than 0.01) and 15 +/- 3.9% (P less than 0.01) respectively. 5. This study has shown that the protective effect of nifedipine against exercise-induced asthma is dose related with the maximum inhibitory effect being observed with a single dose of 20 mg.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689629      PMCID: PMC1386310          DOI: 10.1111/j.1365-2125.1987.tb03201.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides.

Authors:  M K Church; G J Pao; S T Holgate
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

2.  Effects of nifedipine on antigen-induced bronchoconstriction.

Authors:  A F Henderson; R W Heaton; L S Dunlop; J F Costello
Journal:  Am Rev Respir Dis       Date:  1983-05

3.  Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma.

Authors:  D O Williams; P J Barnes; H P Vickers; M Rudolf
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-01

4.  Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.

Authors:  J Cerrina; A Denjean; G Alexandre; A Lockhart; P Duroux
Journal:  Am Rev Respir Dis       Date:  1981-02

5.  Effect of calcium on sulfated mucous glycoprotein secretion in dog trachea.

Authors:  M G Marin; J A Estep; J P Zorn
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-01

6.  Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.

Authors:  T H Lee; L Nagy; T Nagakura; M J Walport; A B Kay
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics.

Authors:  T H Lee; M J Brown; L Nagy; R Causon; M J Walport; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1982-08       Impact factor: 10.793

8.  Inhibition by calcium antagonists of histamine release and calcium influx of rat mast cells: difference between induction of histamine release by concanavalin A and compound 48/80.

Authors:  T Suzuki; K Mori; M Uchida
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

9.  Nifedipine in bronchial asthma.

Authors:  D Patakas; E Vlachoianni; V Tsara; G Louridas; P Argiropoulou
Journal:  J Allergy Clin Immunol       Date:  1983-09       Impact factor: 10.793

10.  A calcium antagonist, nifedipine, modifies exercise-induced asthma.

Authors:  P J Barnes; N M Wilson; M J Brown
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

View more
  1 in total

Review 1.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.